Hindustan Unilever Limited (HINDUNILVR.BO)
INR 2361.05
(-0.23%)
INR 2361.05
(-0.23%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 270.76 Billion INR | 19.99% |
| 2022 | 225.65 Billion INR | 5.3% |
| 2021 | 214.3 Billion INR | 1.74% |
| 2020 | 210.63 Billion INR | 76.9% |
| 2019 | 119.07 Billion INR | 10.82% |
| 2018 | 107.44 Billion INR | 1.73% |
| 2017 | 105.61 Billion INR | 18.13% |
| 2016 | 89.4 Billion INR | -19.95% |
| 2015 | 111.68 Billion INR | 7.55% |
| 2014 | 103.84 Billion INR | 1.71% |
| 2013 | 102.09 Billion INR | 10.9% |
| 2012 | 92.06 Billion INR | 19.44% |
| 2011 | 77.07 Billion INR | 0.03% |
| 2010 | 77.05 Billion INR | 9.55% |
| 2009 | 70.34 Billion INR | 0.0% |
| 2007 | 54.92 Billion INR | 12.31% |
| 2006 | 48.9 Billion INR | 8.04% |
| 2005 | 45.26 Billion INR | -20.14% |
| 2004 | 56.67 Billion INR | -4.18% |
| 2003 | 59.15 Billion INR | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 297.78 Billion INR | 157.91% |
| 2024 Q1 | -514.23 Billion INR | -289.92% |
| 2023 Q4 | 270.76 Billion INR | 0.0% |
| 2023 Q3 | - INR | -100.0% |
| 2023 Q1 | - INR | -100.0% |
| 2023 Q2 | 272.58 Billion INR | 0.0% |
| 2023 FY | 270.76 Billion INR | 19.99% |
| 2022 FY | 225.65 Billion INR | 5.3% |
| 2022 Q1 | - INR | -100.0% |
| 2022 Q3 | - INR | -100.0% |
| 2022 Q4 | 225.65 Billion INR | 0.0% |
| 2022 Q2 | 222.96 Billion INR | 0.0% |
| 2021 Q1 | - INR | -100.0% |
| 2021 FY | 214.3 Billion INR | 1.74% |
| 2021 Q4 | 214.3 Billion INR | 0.0% |
| 2021 Q3 | - INR | -100.0% |
| 2021 Q2 | 213.91 Billion INR | 0.0% |
| 2020 Q3 | - INR | -100.0% |
| 2020 FY | 210.63 Billion INR | 76.9% |
| 2020 Q1 | - INR | -100.0% |
| 2020 Q2 | 208.06 Billion INR | 0.0% |
| 2020 Q4 | 210.63 Billion INR | 0.0% |
| 2019 FY | 119.07 Billion INR | 10.82% |
| 2019 Q4 | 119.07 Billion INR | 0.0% |
| 2019 Q3 | - INR | -100.0% |
| 2019 Q2 | 125.98 Billion INR | 0.0% |
| 2019 Q1 | - INR | -100.0% |
| 2018 Q4 | 107.44 Billion INR | 0.0% |
| 2018 Q1 | - INR | 0.0% |
| 2018 FY | 107.44 Billion INR | 1.73% |
| 2017 FY | 105.61 Billion INR | 18.13% |
| 2016 FY | 89.4 Billion INR | -19.95% |
| 2015 FY | 111.68 Billion INR | 7.55% |
| 2014 FY | 103.84 Billion INR | 1.71% |
| 2013 FY | 102.09 Billion INR | 10.9% |
| 2012 FY | 92.06 Billion INR | 19.44% |
| 2011 FY | 77.07 Billion INR | 0.03% |
| 2010 FY | 77.05 Billion INR | 9.55% |
| 2009 FY | 70.34 Billion INR | 0.0% |
| 2007 FY | 54.92 Billion INR | 12.31% |
| 2006 FY | 48.9 Billion INR | 8.04% |
| 2005 FY | 45.26 Billion INR | -20.14% |
| 2004 FY | 56.67 Billion INR | -4.18% |
| 2003 FY | 59.15 Billion INR | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Ador Multiproducts Limited | 28.52 Million INR | -949002.636% |
| Ambica Agarbathies Aroma & Industries Limited | 1.09 Billion INR | -24518.977% |
| Bajaj Consumer Care Limited | 1.53 Billion INR | -17596.605% |
| Colgate-Palmolive (India) Limited | 13.22 Billion INR | -1947.846% |
| Cupid Limited | 186.52 Million INR | -145059.388% |
| Dabur India Limited | 48.19 Billion INR | -461.789% |
| Emami Limited | 8.21 Billion INR | -3193.957% |
| Gillette India Limited | 8.59 Billion INR | -3050.277% |
| Godrej Consumer Products Limited | 58.97 Billion INR | -359.124% |
| Hipolin Limited | 48.57 Million INR | -557329.024% |
| Honasa Consumer Limited | 5.36 Billion INR | -4944.218% |
| JHS Svendgaard Laboratories Limited | 271.7 Million INR | -99551.83% |
| Jyothy Labs Limited | 5.9 Billion INR | -4483.559% |
| Kaya Limited | 5.22 Billion INR | -5084.604% |
| Marico Limited | 32.52 Billion INR | -732.595% |
| N.K Industries Limited | 22.4 Billion INR | -1108.592% |
| PAOS INDUSTRIES LIMITED | 163.96 Million INR | -165028.774% |
| Paramount Cosmetics (India) Limited | 205.72 Million INR | -131512.59% |
| Pee Cee Cosma Sope Limited | 80.17 Million INR | -337594.409% |
| Procter & Gamble Hygiene and Health Care Limited | 10.83 Billion INR | -2398.477% |